TRADE & SUPPLY CHAINEXPORT ALERT3h ago
Dapagliflozin Exports from India to EU Grow 18% in Q2 2026 Driven by Demand Shift
Export volumes increase across key EU markets amid China supply constraints and inventory destocking, consolidating India's position in the SGLT2 supply chain.
REGULATORY INTELLIGENCEEMA10h ago
EMA Flags Nitrosamine Impurity Across Three Sartan Suppliers; Recall Scope Under Review
Affected lots span valsartan and losartan batches distributed across the EU and UK since Q4 2025, with recall scope and supplier remediation under active review.
CLINICAL & PIPELINEPHASE III READOUT6h ago
Oral PCSK9 Inhibitor Meets Primary Endpoint in 14,000-Patient Cardiovascular Outcomes Trial
Topline data positions the candidate as a potential first-in-class oral therapy; regulatory filing guided for H2 2026.